GNR-139 (aflibercept biosimilar)
/ Generium
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 29, 2026
A Study to Compare GNR-139 and Eylea® in Patients With nAMD
(clinicaltrials.gov)
- P3 | N=180 | Recruiting | Sponsor: AO GENERIUM
New P3 trial • Wet Age-related Macular Degeneration
1 to 1
Of
1
Go to page
1